From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Jimmy Wyman is running the Boston Marathon for his wife, who has a rare form of lung cancer, in support of Dana-Farber.

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

In Sharmila Tagore’s cancer case, early detection was the game changer. Her story serves as both a cautionary tale and a ...

Cancer Research scientists have developed a new cell-based model of lung squamous cell carcinoma (LUSC), a type of lung cancer, which has the potential to develop more effective treatments for the ...

The team from Cancer Research UK's Manchester Institute says it has created a new in vitro model of lung squamous cell ...

These targeted therapies confer the longest survival in non-small cell lung cancer and are better tolerated than cytotoxic agents. The use of ALK inhibitors in the clinic not only increases ...

A phase 1/2 trial of CRISPR-engineered eTIL therapy KSQ-004EX for advanced solid tumors has dosed its first patient.

Baptist Health-Fort Smith introduces the ion robot to enhance early lung cancer detection in the River Valley.